While the selling of patient data for research has been going on for years, this latest gold rush is being driven by the confluence of two specific factors.
Health Data for Sale – Get Yours Here!
read more
While the selling of patient data for research has been going on for years, this latest gold rush is being driven by the confluence of two specific factors.
The move to Value Based Care (VBC) is changing the relationships that pharma has historically had with both payers and providers. The growing chronic disease burden, rise of digital health and commoditization of many drug-disease areas is forcing a rethinking of the underlying pharmaceutical (pharma) business model.
Last week, Microsoft invited me to attend the ePharma conference and assist them with moderating...